Methods for Inhibiting Myostatin Activation by Administering Anti-Pro/Latent Myostatin Antibodies
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/US2016/052014, filed Sep 15, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,287,345 | Methods for Inhibiting Myostatin Activation by Administering Anti-Pro/Latent Myostatin Antibodies In force · Medium confidence UsedRemaining | Scholar Rock, Inc. | In force | Medium confidence | ||
| US 10,751,413 | Anti-Pro/Latent-Myostatin Antibodies and Uses Thereof In force · High confidence | Scholar Rock, Inc. | In force | High confidence | ||
| US 10,882,904 | Methods for Inhibiting Myostatin Activation by Administering Anti-Pro/Latent Myostatin Antibodies In force · Low confidence | Scholar Rock, Inc. | In force | Low confidence | ||
| US 11,439,704 | Methods for Using Anti-Myostatin Antibodies In force · High confidence | Scholar Rock, Inc. | In force | High confidence | ||
| US 12,006,359 | Methods for Altering Body Composition by Administering Anti-Pro/Latent Myostatin Antibodies In force · Low confidence | Scholar Rock, Inc. | In force | Low confidence | ||
| US 12,582,712 | Method of Making Anti-Pro/Latent Myostatin Antibodies In force · High confidence | Scholar Rock, Inc. | In force | High confidence | ||
| Application 18/646,693 | Methods for Inhibiting Myostatin Activation by Administering Anti-Pro/Latent Myostatin Antibodies Abandoned Abandoned Apr 3, 2026 | Scholar Rock, Inc. | Abandoned | Abandoned Apr 3, 2026 | ||
| Application 19/427,341 | Methods for Inhibiting Myostatin Activation by Administering Anti-Pro/Latent Myostatin Antibodies Pending Not granted | Scholar Rock, Inc. | Pending | Not granted | ||
| Application 19/551,523 | Anti-Pro/Latent-Myostatin Antibodies and Uses Thereof Pending Not granted | Scholar Rock, Inc. | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Scholar Rock, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.